SUBSCRIBE
4 minutes
Edinburgh-based Lentitek Ltd, a developer of pioneering manufacturing technologies enabling economic delivery of advanced cell and gene therapies, announced today that it has secured £250,000 ($300,000 USD) in seed investment. This investment will be deployed to further advance its technology
